}

Ibnsina Pharma records 50% YoY consolidated profit surge in 9 months

Updated 11/16/2026 5:23:00 AM
Ibnsina Pharma records 50% YoY consolidated profit surge in 9 months

Arab Finance: Ibnsina Pharma (ISPH) recorded consolidated net profit attributable to the holding company of EGP 908.835 million in the first nine months of 2026, up 50% year on year (YoY) from EGP 605.843 million, the company’s financial statements unveiled.

The company’s net sales also soared during the nine months, reaching EGP 68.063 billion, compared to EGP 55.394 billion in the same period of 2025.

Earnings per share stood at EGP 0.73 in January-September 2026, up from EGP 0.53 in the year-ago period.

Meanwhile, the company’s standalone net profit rose to EGP 851.106 million from EGP 638.916 million.

Established in 2001, Ibnsina Pharma is a leading pharmaceutical distribution and healthcare supply chain company.

Related News